Sees Q1 Center Margin $118M-$132M, and Adjusted EBITDA $39M-$45M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFST:
- LifeStance: Improving Utilization, Stronger Fundamentals, and Tech-Driven Growth Support Buy Rating
- Lifestance Health Group, Inc. (LFST) Q4 Earnings Cheat Sheet
- LifeStance price target raised to $11 from $10 at BTIG
- LifeStance Health Group: Operational Efficiency Initiatives Undervalued, Supporting Buy Rating and Upside Potential
- LifeStance price target raised to $8.50 from $6.50 at KeyBanc